The IL-17 receptor (IL-17R) superfamily includes cytokines and receptors with unique structural and signaling features. IL-17A, a key cytokine of T helper 17 (Th17) cells, plays a critical role in host defense against extracellular pathogens but also contributes to inflammatory diseases. IL-17A and its receptor (IL-17RA) are part of a new subfamily of cytokines and receptors. IL-17 family members, including IL-17A, IL-17F, IL-17E (IL-25), and others, have distinct biological functions and signaling pathways. IL-17A and IL-17F signal through the IL-17RA and IL-17RC receptor complex, which is essential for their biological activities. IL-17RA is a common signaling subunit used by multiple ligands, and its expression is dynamically regulated. The signaling pathways activated by IL-17RA include NF-κB, MAPK, and C/EBP, which are crucial for inflammatory responses. IL-17RC, IL-17RB, and IL-17RD are other members of the IL-17R family, each with distinct roles in signaling. The IL-17R family has unique structural features and signaling pathways that differ from other cytokine receptors, particularly those involved in adaptive immunity. IL-17 signaling bridges innate and adaptive immunity, making it a key target for therapeutic interventions in autoimmune diseases. Understanding the molecular mechanisms of IL-17 signaling is essential for developing effective treatments. Current research focuses on targeting IL-17 family members and their receptors to treat autoimmune conditions. The IL-17R family's unique signaling properties and roles in inflammation highlight its importance in immunology and medicine.The IL-17 receptor (IL-17R) superfamily includes cytokines and receptors with unique structural and signaling features. IL-17A, a key cytokine of T helper 17 (Th17) cells, plays a critical role in host defense against extracellular pathogens but also contributes to inflammatory diseases. IL-17A and its receptor (IL-17RA) are part of a new subfamily of cytokines and receptors. IL-17 family members, including IL-17A, IL-17F, IL-17E (IL-25), and others, have distinct biological functions and signaling pathways. IL-17A and IL-17F signal through the IL-17RA and IL-17RC receptor complex, which is essential for their biological activities. IL-17RA is a common signaling subunit used by multiple ligands, and its expression is dynamically regulated. The signaling pathways activated by IL-17RA include NF-κB, MAPK, and C/EBP, which are crucial for inflammatory responses. IL-17RC, IL-17RB, and IL-17RD are other members of the IL-17R family, each with distinct roles in signaling. The IL-17R family has unique structural features and signaling pathways that differ from other cytokine receptors, particularly those involved in adaptive immunity. IL-17 signaling bridges innate and adaptive immunity, making it a key target for therapeutic interventions in autoimmune diseases. Understanding the molecular mechanisms of IL-17 signaling is essential for developing effective treatments. Current research focuses on targeting IL-17 family members and their receptors to treat autoimmune conditions. The IL-17R family's unique signaling properties and roles in inflammation highlight its importance in immunology and medicine.